Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6*1 and CYP2D6*10 using cell-based models in vitro

被引：0
|
作者：
Qiang Qu
Jian Qu
Lu Han
Min Zhan
Lan-xiang Wu
Yi-wen Zhang
Wei Zhang
Hong-hao Zhou
机构：
[1] Institute of Clinical Pharmacology,
[2] Hunan Key Laboratory of Pharmacogenetics,undefined
[3] Xiangya Hospital,undefined
[4] Central South University,undefined
[5] Xiangya Hospital,undefined
[6] Central South University,undefined
[7] Institute of Life Sciences,undefined
[8] Chongqing Medical University,undefined
来源：
Acta Pharmacologica Sinica | 2014年 / 35卷
关键词：
CYP2D6; drug interaction; herbal medicine; coptisine; bilobalide; schizandrin; luteolin; puerarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：685 / 696
页数：11
相关论文
共 50 条
  • [41] The CYP2D6 VCF Translator
    Qiao, W.
    Wang, J.
    Pullman, B. S.
    Chen, R.
    Yang, Y.
    Scott, S. A.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (04): : 301 - 303
  • [42] The CYP2D6 VCF Translator
    W Qiao
    J Wang
    B S Pullman
    R Chen
    Y Yang
    S A Scott
    The Pharmacogenomics Journal, 2017, 17 : 301 - 303
  • [43] Understanding CYP2D6 interactions
    de Groot, Marcel J.
    Wakenhut, Florian
    Whitlock, Gavin
    Hyland, Ruth
    DRUG DISCOVERY TODAY, 2009, 14 (19-20) : 964 - 972
  • [44] CYP2D6, serotonin and suicide
    Ahlner, Johan
    Zackrisson, Anna-Lena
    Lindblom, Bertil
    Bertilsson, Leif
    PHARMACOGENOMICS, 2010, 11 (07) : 903 - 905
  • [45] CYP2D6 phenotyping with dextromethorphan
    Wojtczak, Anna
    Rychlik-Sych, Mariola
    Krochmalska-Ulacha, Eliza
    Skretkowicz, Jadwiga
    PHARMACOLOGICAL REPORTS, 2007, 59 (06) : 734 - 738
  • [46] CYP2D6 genotyping and codeine
    De Leon, Jose
    PEDIATRIC ANESTHESIA, 2008, 18 (03) : 274 - 275
  • [47] PharmVar GeneFocus: CYP2D6
    Nofziger, Charity
    Turner, Amy J.
    Sangkuhl, Katrin
    Whirl-Carrillo, Michelle
    Agundez, Jose A. G.
    Black, John L.
    Dunnenberger, Henry M.
    Ruano, Gualberto
    Kennedy, Martin A.
    Phillips, Michael S.
    Hachad, Houda
    Klein, Teri E.
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 154 - 170
  • [48] MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers
    de la Torre, R
    Farré, M
    Mathúna, BO
    Roset, PN
    Pizarro, N
    Segura, M
    Torrens, M
    Ortuño, J
    Pujadas, M
    Camí, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (07) : 551 - 554
  • [49] MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers
    Rafael de la Torre
    Magí Farré
    Brian Ó Mathúna
    Pere N. Roset
    Neus Pizarro
    Mireia Segura
    Marta Torrens
    Jordi Ortuño
    Mitona Pujadas
    Jordi Camí
    European Journal of Clinical Pharmacology, 2005, 61 : 551 - 554
  • [50] Metoclopramide-induced acute dystonic reaction caused by CYP2D6*4/*4 and CYP2D6*10/*10 genotypes
    Sarac, I.
    Sarac, H.
    Borovecki, F.
    Bozina, N.
    Ivek, I.
    Krakan, L. Bagaric
    Kresic, Z.
    MOVEMENT DISORDERS, 2023, 38 : S371 - S371
12345